Eventide Asset Management - Q4 2019 holdings

$3.55 Billion is the total value of Eventide Asset Management's 116 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 40.3% .

 Value Shares↓ Weighting
ASND  ASCENDIS PHARMA A Ssponsored adr$236,316,000
+44.4%
1,698,6480.0%6.66%
+23.2%
ZGNX  ZOGENIX INC$148,117,000
+30.2%
2,841,3000.0%4.17%
+11.0%
SRPT SellSAREPTA THERAPEUTICS INC$128,524,000
+40.0%
996,000
-18.3%
3.62%
+19.3%
TTD  THE TRADE DESK INC$110,407,000
+38.5%
425,0000.0%3.11%
+18.1%
AIMT  AIMMUNE THERAPEUTICS INC$103,221,000
+59.8%
3,084,0000.0%2.91%
+36.3%
BHVN  BIOHAVEN PHARMACTL HLDG CO L$88,955,000
+30.5%
1,634,0000.0%2.51%
+11.3%
FIVN  FIVE9 INC$81,975,000
+22.0%
1,250,0000.0%2.31%
+4.1%
TWLO  TWILIO INCcl a$81,278,000
-10.6%
827,0000.0%2.29%
-23.8%
ROP  ROPER TECHNOLOGIES INC$75,805,000
-0.7%
214,0000.0%2.14%
-15.3%
WCN  WASTE CONNECTIONS INC$72,995,000
-1.3%
804,0000.0%2.06%
-15.8%
LOW BuyLOWES COS INC$70,706,000
+10.5%
590,400
+1.5%
1.99%
-5.8%
PANW  PALO ALTO NETWORKS INC$66,369,000
+13.5%
287,0000.0%1.87%
-3.3%
SPLK  SPLUNK INC$64,102,000
+27.1%
428,0000.0%1.81%
+8.3%
MYOV SellMYOVANT SCIENCES LTD$64,038,000
+162.3%
4,126,131
-12.1%
1.80%
+123.5%
XYL BuyXYLEM INC$62,228,000
-0.7%
789,800
+0.3%
1.75%
-15.4%
LRCX SellLAM RESEARCH CORP$58,772,000
+12.0%
201,000
-11.5%
1.66%
-4.4%
MTD  METTLER TOLEDO INTERNATIONAL$57,600,000
+12.6%
72,6100.0%1.62%
-4.0%
SAGE  SAGE THERAPEUTICS INC$57,030,000
-48.5%
790,0000.0%1.61%
-56.1%
NEP BuyNEXTERA ENERGY PARTNERS LP$56,121,000
-0.2%
1,065,922
+0.2%
1.58%
-14.9%
HUBS  HUBSPOT INC$55,475,000
+4.5%
350,0000.0%1.56%
-10.8%
ASML BuyASML HOLDING N V$53,536,000
+20.8%
180,900
+1.4%
1.51%
+3.0%
W  WAYFAIR INCcl a$51,782,000
-19.4%
573,0000.0%1.46%
-31.3%
MGTA BuyMAGENTA THERAPEUTICS INC$51,451,000
+69.7%
3,393,894
+14.8%
1.45%
+44.7%
COLL  COLLEGIUM PHARMACEUTICAL INC$49,968,000
+79.3%
2,427,9760.0%1.41%
+52.9%
LII  LENNOX INTL INC$48,794,000
+0.4%
200,0000.0%1.38%
-14.4%
ARGX BuyARGENX SEsponsored adr$47,723,000
+82.1%
297,300
+29.3%
1.34%
+55.3%
VMC BuyVULCAN MATLS CO$45,918,000
-4.3%
318,900
+0.5%
1.29%
-18.4%
CCI BuyCROWN CASTLE INTL CORP NEW$45,929,000
+3.7%
323,100
+1.4%
1.29%
-11.6%
EXAS  EXACT SCIENCES CORP$45,778,000
+2.3%
495,0000.0%1.29%
-12.7%
GWPH BuyGW PHARMACEUTICALS PLCads$45,588,000
+126.5%
436,000
+149.1%
1.28%
+93.2%
MYOK  MYOKARDIA INC$45,262,000
+39.8%
621,0000.0%1.28%
+19.2%
STML  STEMLINE THERAPEUTICS INC$44,227,000
+2.1%
4,160,6080.0%1.25%
-12.9%
SMAR  SMARTSHEET INC$43,797,000
+24.7%
975,0000.0%1.23%
+6.3%
BEP BuyBROOKFIELD RENEWABLE PARTNERpartnership unit$42,536,000
+1148.1%
912,200
+987.2%
1.20%
+961.1%
GBT  GLOBAL BLOOD THERAPEUTICS IN$42,527,000
+63.8%
535,0000.0%1.20%
+39.6%
POOL  POOL CORPORATION$39,290,000
+5.3%
185,0000.0%1.11%
-10.2%
MRTX  MIRATI THERAPEUTICS INC$38,787,000
+65.4%
301,0000.0%1.09%
+41.0%
NBIX  NEUROCRINE BIOSCIENCES INC$37,944,000
+19.3%
353,0000.0%1.07%
+1.7%
BPMC  BLUEPRINT MEDICINES CORP$37,011,000
+9.0%
462,0000.0%1.04%
-7.0%
QURE  UNIQURE NV$35,830,000
+82.1%
500,0000.0%1.01%
+55.4%
IPHI SellINPHI CORP$33,309,000
-1.7%
450,000
-18.9%
0.94%
-16.2%
VRNS  VARONIS SYS INC$32,638,000
+30.0%
420,0000.0%0.92%
+10.8%
MGA  MAGNA INTL INC$32,191,000
+2.8%
587,0000.0%0.91%
-12.3%
RCKT  ROCKET PHARMACEUTICALS INC$32,205,000
+95.4%
1,415,0000.0%0.91%
+66.4%
KALV  KALVISTA PHARMACEUTICALS INC$29,921,000
+53.5%
1,680,0000.0%0.84%
+30.9%
CTAS  CINTAS CORP$29,868,000
+0.4%
111,0000.0%0.84%
-14.3%
IAA  IAA INC$28,707,000
+12.8%
610,0000.0%0.81%
-3.8%
TREX NewTREX CO INC$26,874,000299,000
+100.0%
0.76%
IDXX  IDEXX LABS INC$26,870,000
-4.0%
102,9000.0%0.76%
-18.2%
ODFL BuyOLD DOMINION FREIGHT LINE IN$26,645,000
+16.1%
140,400
+4.0%
0.75%
-0.9%
PAYC SellPAYCOM SOFTWARE INC$26,476,000
-10.4%
100,000
-29.1%
0.75%
-23.6%
AVRO  AVROBIO INC$26,276,000
+42.6%
1,305,3070.0%0.74%
+21.5%
VCYT  VERACYTE INC$25,966,000
+16.3%
930,0000.0%0.73%
-0.7%
APTV SellAPTIV PLC$25,518,000
+2.1%
268,700
-6.0%
0.72%
-13.0%
LEA  LEAR CORP$25,245,000
+16.4%
184,0000.0%0.71%
-0.8%
NOVT NewNOVANTA INC$24,763,000280,000
+100.0%
0.70%
HASI BuyHANNON ARMSTRONG SUST INFR C$24,505,000
+18.4%
761,500
+7.3%
0.69%
+0.9%
MNTA  MOMENTA PHARMACEUTICALS INC$24,386,000
+52.2%
1,236,0000.0%0.69%
+29.9%
CRNX  CRINETICS PHARMACEUTICALS IN$23,760,000
+66.8%
947,0000.0%0.67%
+42.0%
AY BuyATLANTICA YIELD PLC$20,969,000
+10.7%
794,600
+1.0%
0.59%
-5.6%
DT NewDYNATRACE INC$20,870,000824,900
+100.0%
0.59%
ESTC BuyELASTIC N V$20,576,000
+66.6%
320,000
+113.3%
0.58%
+42.2%
PFPT  PROOFPOINT INC$18,135,000
-11.1%
158,0000.0%0.51%
-24.2%
XPO  XPO LOGISTICS INC$17,534,000
+11.4%
220,0000.0%0.49%
-5.0%
IMVTU NewIMMUNOVANT INCunit 12/18/2024 added$16,912,000680,000
+100.0%
0.48%
XENE  XENON PHARMACEUTICALS INC$16,703,000
+45.5%
1,274,1000.0%0.47%
+24.3%
KRTX SellKARUNA THERAPEUTICS INC$16,186,000
+235.0%
214,843
-27.4%
0.46%
+185.0%
ISRG  INTUITIVE SURGICAL INC$14,779,000
+9.5%
25,0000.0%0.42%
-6.7%
PHAT NewPHATHOM PHARMACEUTICALS INC$14,013,000450,000
+100.0%
0.40%
STRO BuySUTRO BIOPHARMA INC$13,694,000
+187.0%
1,244,895
+137.1%
0.39%
+144.3%
ICPT NewINTERCEPT PHARMACEUTICALS IN$12,392,000100,000
+100.0%
0.35%
MDB  MONGODB INCcl a$12,174,000
+9.2%
92,5000.0%0.34%
-6.8%
EXR  EXTRA SPACE STORAGE INC$11,618,000
-9.6%
110,0000.0%0.33%
-23.1%
OKTA SellOKTA INCcl a$11,537,000
-21.9%
100,000
-33.3%
0.32%
-33.4%
DDOG  DATADOG INC$11,334,000
+11.4%
300,0000.0%0.32%
-5.1%
RGEN  REPLIGEN CORP$11,008,000
+20.6%
119,0000.0%0.31%
+2.6%
GLPG SellGALAPAGOS NVspon adr$10,548,000
-60.1%
51,000
-70.5%
0.30%
-66.0%
EPIX  ESSA PHARMA INC$10,503,000
+63.2%
2,010,1690.0%0.30%
+39.0%
XNCR  XENCOR INC$10,317,000
+2.0%
300,0000.0%0.29%
-12.9%
ETNB New89BIO INC$9,202,000350,000
+100.0%
0.26%
ARYAU  ARYA SCIENCES ACQUISITION COunit 10/04/2023$9,200,000
+4.9%
800,0000.0%0.26%
-10.7%
STSA  SATSUMA PHARMACEUTICALS INC$8,364,000
+31.1%
425,0000.0%0.24%
+11.8%
FENC  FENNEC PHARMACEUTICALS INC$4,666,000
+34.7%
720,0000.0%0.13%
+14.9%
ETTX BuyENTASIS THERAPEUTICS HLDGS I$4,300,000
+87.9%
879,541
+124.1%
0.12%
+59.2%
ARE BuyALEXANDRIA REAL ESTATE EQ IN$3,943,000
+38.4%
24,400
+31.9%
0.11%
+18.1%
ORTX  ORCHARD THERAPEUTICS PLCads$3,713,000
+15.7%
270,0000.0%0.10%
-0.9%
PLD BuyPROLOGIS INC$3,289,000
+58.8%
36,900
+51.9%
0.09%
+36.8%
FHN BuyFIRST HORIZON NATL CORP$3,267,000
+88.6%
197,300
+84.6%
0.09%
+61.4%
NEE BuyNEXTERA ENERGY INC$3,197,000
+16.3%
13,200
+11.9%
0.09%
-1.1%
OKE BuyONEOK INC NEW$3,087,000
+33.0%
40,800
+29.5%
0.09%
+13.0%
CMS NewCMS ENERGY CORP$2,953,00047,000
+100.0%
0.08%
A BuyAGILENT TECHNOLOGIES INC$2,790,000
+86.7%
32,700
+67.7%
0.08%
+61.2%
EQIX BuyEQUINIX INC$2,685,000
+22.5%
4,600
+21.1%
0.08%
+5.6%
LW BuyLAMB WESTON HLDGS INC$2,710,000
+372.1%
31,500
+298.7%
0.08%
+300.0%
FRC BuyFIRST REP BK SAN FRANCISCO C$2,549,000
+48.9%
21,700
+22.6%
0.07%
+26.3%
WM BuyWASTE MGMT INC DEL$2,427,000
+8.2%
21,300
+9.2%
0.07%
-8.1%
BXP NewBOSTON PROPERTIES INC$2,413,00017,500
+100.0%
0.07%
IR BuyINGERSOLL-RAND PLC$2,313,000
+19.6%
17,400
+10.8%
0.06%
+1.6%
BuyPALO ALTO NETWORKS INCnote 0.750% 7/0$2,089,000
+23.6%
1,890,000
+18.1%
0.06%
+5.4%
BuyNEUROCRINE BIOSCIENCES INCnote 2.250% 5/1$1,997,000
+45.6%
1,300,000
+30.0%
0.06%
+24.4%
JCI BuyJOHNSON CTLS INTL PLC$1,946,000
+50.3%
47,800
+62.0%
0.06%
+27.9%
ZBH NewZIMMER BIOMET HLDGS INC$1,676,00011,200
+100.0%
0.05%
IEX BuyIDEX CORP$1,582,000
+48.5%
9,200
+41.5%
0.04%
+28.6%
ZTS NewZOETIS INCcl a$1,324,00010,000
+100.0%
0.04%
DHI NewD R HORTON INC$1,113,00021,100
+100.0%
0.03%
KLAC NewKLA CORPORATION$1,016,0005,700
+100.0%
0.03%
NewINTERCEPT PHARMACEUTICALS INnote 2.000% 5/1$981,000736,000
+100.0%
0.03%
NewSAREPTA THERAPEUTICS INCdbcv 1.500%11/1$941,000483,000
+100.0%
0.03%
BWA NewBORGWARNER INC$963,00022,200
+100.0%
0.03%
FNB NewFNB CORP PA$975,00076,800
+100.0%
0.03%
NewINTERCEPT PHARMACEUTICALS INnote 3.250% 7/0$829,000820,000
+100.0%
0.02%
TER NewTERADYNE INC$743,00010,900
+100.0%
0.02%
INFO NewIHS MARKIT LTD$708,0009,400
+100.0%
0.02%
SIVB NewSVB FINL GROUP$577,0002,300
+100.0%
0.02%
CCIPRA  CROWN CASTLE INTL CORP NEW6.875% con pfd a$410,000
+1.5%
3200.0%0.01%
-7.7%
MLHR SellMILLER HERMAN INC$383,000
-61.0%
9,200
-56.8%
0.01%
-65.6%
WELL ExitWELLTOWER INC$0-1,900
-100.0%
-0.01%
ETN ExitEATON CORP PLC$0-2,100
-100.0%
-0.01%
GPMT ExitGRANITE PT MTG TR INC$0-9,000
-100.0%
-0.01%
ERIC ExitERICSSONadr b sek 10$0-24,100
-100.0%
-0.01%
TSM ExitTAIWAN SEMICONDUCTOR MFG LTDsponsored ads$0-4,800
-100.0%
-0.01%
HMC ExitHONDA MOTOR LTD$0-9,100
-100.0%
-0.01%
ABB ExitABB LTDsponsored adr$0-16,000
-100.0%
-0.01%
EQR ExitEQUITY RESIDENTIALsh ben int$0-4,100
-100.0%
-0.01%
ExitMEDICINES COnote 2.750% 7/1$0-400,000
-100.0%
-0.02%
ESS ExitESSEX PPTY TR INC$0-1,800
-100.0%
-0.02%
NVDA ExitNVIDIA CORP$0-3,700
-100.0%
-0.02%
NOK ExitNOKIA CORPsponsored adr$0-288,800
-100.0%
-0.05%
WMB ExitWILLIAMS COS INC DEL$0-62,700
-100.0%
-0.05%
NXPI ExitNXP SEMICONDUCTORS N V$0-14,500
-100.0%
-0.05%
VTR ExitVENTAS INC$0-23,400
-100.0%
-0.06%
TERP ExitTERRAFORM PWR INC$0-92,800
-100.0%
-0.06%
CBIO ExitCATALYST BIOSCIENCES INC$0-462,852
-100.0%
-0.08%
HCP ExitHCP INC$0-74,200
-100.0%
-0.09%
THOR ExitSYNTHORX INC$0-400,000
-100.0%
-0.22%
HSACU ExitHEALTH SCIENCES ACQUSTN CORPunit 04/01/2024$0-680,000
-100.0%
-0.24%
STKL ExitSUNOPTA INC$0-4,132,375
-100.0%
-0.25%
INST ExitINSTRUCTURE INC$0-330,000
-100.0%
-0.42%
BOLD ExitAUDENTES THERAPEUTICS INC$0-499,000
-100.0%
-0.46%
KAR ExitKAR AUCTION SVCS INC$0-610,000
-100.0%
-0.50%
FOLD ExitAMICUS THERAPEUTICS INC$0-1,950,000
-100.0%
-0.52%
RARX ExitRA PHARMACEUTICALS INC$0-743,000
-100.0%
-0.58%
ANET ExitARISTA NETWORKS INC$0-117,000
-100.0%
-0.92%
PEGI ExitPATTERN ENERGY GROUP INCcl a$0-1,073,200
-100.0%
-0.96%
SERV ExitSERVICEMASTER GLOBAL HLDGS I$0-750,000
-100.0%
-1.38%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-01-29
Signatures

The EDGAR filing(s) were signed by:

About Eventide Asset Management

Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.

The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.

The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.

Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.

Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
LOWES COS INC40Q3 20233.2%
PALO ALTO NETWORKS INC40Q3 20233.6%
ASML HOLDINGS NV40Q3 20231.9%
NEUROCRINE BIOSCIENCES INC40Q3 20231.1%
REPLIGEN CORP40Q3 20230.5%
VERACYTE INC38Q3 20231.5%
LAM RESEARCH CORP35Q3 20233.4%
XPO LOGISTICS INC34Q1 20233.8%
COLLEGIUM PHARMACEUTICAL INC34Q3 20232.6%
MAGNA INTL INC33Q4 20212.5%

View Eventide Asset Management's complete holdings history.

Latest significant ownerships (13-D/G)
Eventide Asset Management Q4 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Cogent Biosciences, Inc.February 14, 20232,589,7783.7%
ESSA Pharma Inc.Sold outFebruary 14, 202300.0%
Freeline Therapeutics Holdings plcFebruary 14, 20235,920,7659.1%
KnowBe4, Inc.Sold outFebruary 14, 202300.0%
Praxis Precision Medicines, Inc.February 14, 20233,518,0627.5%
Prometheus Biosciences, Inc.February 14, 20231,032,9382.2%
SUTRO BIOPHARMA, INC.Sold outFebruary 14, 202300.0%
Vital Farms, Inc.Sold outFebruary 14, 202300.0%
Zymeworks Inc.Sold outFebruary 14, 202300.0%
Entasis Therapeutics Holdings Inc.February 14, 2022590,6021.2%

View Eventide Asset Management's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR/A2024-02-20
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View Eventide Asset Management's complete filings history.

Compare quarters

Export Eventide Asset Management's holdings